Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus
Sodium-glucose cotransporter 2 inhibitor tofogliflozin is a new type of antidiabetic drug for individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to examine in which type of individuals and/or under which conditions tofogliflozin could exert more beneficial effects on body co...
Saved in:
| Main Authors: | Shinji Kamei, Masahiro Iwamoto, Miyuki Kameyama, Masashi Shimoda, Tomoe Kinoshita, Atsushi Obata, Tomohiko Kimura, Hidenori Hirukawa, Fuminori Tatsumi, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2018/6470137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus
by: Masashi Shimoda, et al.
Published: (2017-01-01) -
Comprehensive Search for GPCR Compounds which Can Enhance MafA and/or PDX-1 Expression Levels Using a Small Molecule Compound Library
by: Hideaki Kaneto, et al.
Published: (2023-01-01) -
Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study
by: Tomohiko Kimura, et al.
Published: (2024-01-01) -
Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patients
by: Yuichiro Iwamoto, et al.
Published: (2025-01-01) -
Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis
by: Yuichiro Iwamoto, et al.
Published: (2024-05-01)